Cargando…

Clinical association of baseline levels of conjugated dienes in low-density lipoprotein and nitric oxide with aggressive B-cell non-Hodgkin lymphoma and their relationship with immunoglobulins and Th1-to-Th2 ratio

OBJECTIVE: The aim of this study was to highlight the clinical association of baseline levels of conjugated dienes in low-density lipoprotein (LDL-BCD) and nitric oxide (NO) with immunoglobulins (Igs) and T helper (Th)1/Th2 ratio in patients with newly diagnosed B-cell non-Hodgkin lymphoma (NHL). PA...

Descripción completa

Detalles Bibliográficos
Autores principales: Haddouche, Mustapha, Meziane, Warda, Hadjidj, Zeyneb, Mesli, Naima, Aribi, Mourad
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4898418/
https://www.ncbi.nlm.nih.gov/pubmed/27330333
http://dx.doi.org/10.2147/JBM.S103967
_version_ 1782436353241251840
author Haddouche, Mustapha
Meziane, Warda
Hadjidj, Zeyneb
Mesli, Naima
Aribi, Mourad
author_facet Haddouche, Mustapha
Meziane, Warda
Hadjidj, Zeyneb
Mesli, Naima
Aribi, Mourad
author_sort Haddouche, Mustapha
collection PubMed
description OBJECTIVE: The aim of this study was to highlight the clinical association of baseline levels of conjugated dienes in low-density lipoprotein (LDL-BCD) and nitric oxide (NO) with immunoglobulins (Igs) and T helper (Th)1/Th2 ratio in patients with newly diagnosed B-cell non-Hodgkin lymphoma (NHL). PATIENTS AND METHODS: Thirty-two newly diagnosed patients with aggressive B-cell NHL and 25 age-, sex-, and body-mass-index-matched healthy controls were randomly selected for a cross-sectional case–control study conducted at the Hematology Department of Tlemcen Medical Centre University (northwest of Algeria). RESULTS: Circulating levels of LDL-BCD and NO and those of IgA and IgM were significantly higher in patients than in controls. The levels of Th1/Th2 ratio and plasma total antioxidant capacity were significantly lower in patients compared with controls, while malondialdehyde and protein carbonyl levels were significantly higher in patients. B-cell NHL was significantly associated with high levels of LDL-BCD from 25th to 75th percentile (25th percentile: relative risk [RR] =2.26, 95% confidence interval [CI] 1.42–3.59, P=0.014; 50th percentile: RR =2.84, 95% CI 1.72–4.68, P<0.001; 75th percentile: RR =5.43, 95% CI 2.58–11.42, P<0.001). Similarly, the disease was significantly associated with high levels of NO production from 25th to 75th percentile (25th percentile: RR =2.07, 95% CI 1.25–3.44, P=0.024; 50th percentile: RR =2.78, 95% CI 1.63–4.72, P<0.001; 75th percentile: RR =4.68, 95% CI 2.21–9.91, P<0.001). Moreover, LDL-BCD levels were positively and significantly correlated with interferon (IFN)-γ, whereas NO levels were inversely and significantly correlated with IFN-γ and Th1/Th2 ratio. CONCLUSION: LDL-BCD and NO production seem to be associated with aggressive B-cell NHL and alteration of Th1/Th2 ratio. Our results have to be examined using ex vivo mechanistic studies leading to further investigations of these parameters, with an interest in the link between Epstein–Barr virus infection and NO and immunoglobulins.
format Online
Article
Text
id pubmed-4898418
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Dove Medical Press
record_format MEDLINE/PubMed
spelling pubmed-48984182016-06-21 Clinical association of baseline levels of conjugated dienes in low-density lipoprotein and nitric oxide with aggressive B-cell non-Hodgkin lymphoma and their relationship with immunoglobulins and Th1-to-Th2 ratio Haddouche, Mustapha Meziane, Warda Hadjidj, Zeyneb Mesli, Naima Aribi, Mourad J Blood Med Original Research OBJECTIVE: The aim of this study was to highlight the clinical association of baseline levels of conjugated dienes in low-density lipoprotein (LDL-BCD) and nitric oxide (NO) with immunoglobulins (Igs) and T helper (Th)1/Th2 ratio in patients with newly diagnosed B-cell non-Hodgkin lymphoma (NHL). PATIENTS AND METHODS: Thirty-two newly diagnosed patients with aggressive B-cell NHL and 25 age-, sex-, and body-mass-index-matched healthy controls were randomly selected for a cross-sectional case–control study conducted at the Hematology Department of Tlemcen Medical Centre University (northwest of Algeria). RESULTS: Circulating levels of LDL-BCD and NO and those of IgA and IgM were significantly higher in patients than in controls. The levels of Th1/Th2 ratio and plasma total antioxidant capacity were significantly lower in patients compared with controls, while malondialdehyde and protein carbonyl levels were significantly higher in patients. B-cell NHL was significantly associated with high levels of LDL-BCD from 25th to 75th percentile (25th percentile: relative risk [RR] =2.26, 95% confidence interval [CI] 1.42–3.59, P=0.014; 50th percentile: RR =2.84, 95% CI 1.72–4.68, P<0.001; 75th percentile: RR =5.43, 95% CI 2.58–11.42, P<0.001). Similarly, the disease was significantly associated with high levels of NO production from 25th to 75th percentile (25th percentile: RR =2.07, 95% CI 1.25–3.44, P=0.024; 50th percentile: RR =2.78, 95% CI 1.63–4.72, P<0.001; 75th percentile: RR =4.68, 95% CI 2.21–9.91, P<0.001). Moreover, LDL-BCD levels were positively and significantly correlated with interferon (IFN)-γ, whereas NO levels were inversely and significantly correlated with IFN-γ and Th1/Th2 ratio. CONCLUSION: LDL-BCD and NO production seem to be associated with aggressive B-cell NHL and alteration of Th1/Th2 ratio. Our results have to be examined using ex vivo mechanistic studies leading to further investigations of these parameters, with an interest in the link between Epstein–Barr virus infection and NO and immunoglobulins. Dove Medical Press 2016-05-31 /pmc/articles/PMC4898418/ /pubmed/27330333 http://dx.doi.org/10.2147/JBM.S103967 Text en © 2016 Haddouche et al. This work is published and licensed by Dove Medical Press Limited The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed.
spellingShingle Original Research
Haddouche, Mustapha
Meziane, Warda
Hadjidj, Zeyneb
Mesli, Naima
Aribi, Mourad
Clinical association of baseline levels of conjugated dienes in low-density lipoprotein and nitric oxide with aggressive B-cell non-Hodgkin lymphoma and their relationship with immunoglobulins and Th1-to-Th2 ratio
title Clinical association of baseline levels of conjugated dienes in low-density lipoprotein and nitric oxide with aggressive B-cell non-Hodgkin lymphoma and their relationship with immunoglobulins and Th1-to-Th2 ratio
title_full Clinical association of baseline levels of conjugated dienes in low-density lipoprotein and nitric oxide with aggressive B-cell non-Hodgkin lymphoma and their relationship with immunoglobulins and Th1-to-Th2 ratio
title_fullStr Clinical association of baseline levels of conjugated dienes in low-density lipoprotein and nitric oxide with aggressive B-cell non-Hodgkin lymphoma and their relationship with immunoglobulins and Th1-to-Th2 ratio
title_full_unstemmed Clinical association of baseline levels of conjugated dienes in low-density lipoprotein and nitric oxide with aggressive B-cell non-Hodgkin lymphoma and their relationship with immunoglobulins and Th1-to-Th2 ratio
title_short Clinical association of baseline levels of conjugated dienes in low-density lipoprotein and nitric oxide with aggressive B-cell non-Hodgkin lymphoma and their relationship with immunoglobulins and Th1-to-Th2 ratio
title_sort clinical association of baseline levels of conjugated dienes in low-density lipoprotein and nitric oxide with aggressive b-cell non-hodgkin lymphoma and their relationship with immunoglobulins and th1-to-th2 ratio
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4898418/
https://www.ncbi.nlm.nih.gov/pubmed/27330333
http://dx.doi.org/10.2147/JBM.S103967
work_keys_str_mv AT haddouchemustapha clinicalassociationofbaselinelevelsofconjugateddienesinlowdensitylipoproteinandnitricoxidewithaggressivebcellnonhodgkinlymphomaandtheirrelationshipwithimmunoglobulinsandth1toth2ratio
AT mezianewarda clinicalassociationofbaselinelevelsofconjugateddienesinlowdensitylipoproteinandnitricoxidewithaggressivebcellnonhodgkinlymphomaandtheirrelationshipwithimmunoglobulinsandth1toth2ratio
AT hadjidjzeyneb clinicalassociationofbaselinelevelsofconjugateddienesinlowdensitylipoproteinandnitricoxidewithaggressivebcellnonhodgkinlymphomaandtheirrelationshipwithimmunoglobulinsandth1toth2ratio
AT meslinaima clinicalassociationofbaselinelevelsofconjugateddienesinlowdensitylipoproteinandnitricoxidewithaggressivebcellnonhodgkinlymphomaandtheirrelationshipwithimmunoglobulinsandth1toth2ratio
AT aribimourad clinicalassociationofbaselinelevelsofconjugateddienesinlowdensitylipoproteinandnitricoxidewithaggressivebcellnonhodgkinlymphomaandtheirrelationshipwithimmunoglobulinsandth1toth2ratio